In all the excitement I forgot until I just picked up my granddaughter that in fourth quarter 2018 the results of the Paediatric Nash trials will be also released.
It would seem now highly probable that these results will also be as promising which opens up an entirely different addressable market given that IMC has such a low adverse event profile.
Perhaps Macca's will one day have a dispenser at every register so that paediatric Nash can be addressed at source.
Add to My Watchlist
What is My Watchlist?
